Showing results (121-130 of 167) with videos related to

Sort By:
Pageof 17
Journal of Neuroinflammation|June 17, 2020
Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosisWendy Gilmore, Brett T Lund, Peili Li, et al.
The Lancet. Neurology|July 11, 2014
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imagingOlga Ciccarelli, Frederik Barkhof, Benedetta Bodini, et al.
Annals of Neurology|August 29, 2012
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosisEllen M Mowry, Emmanuelle Waubant, Charles E McCulloch, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 14, 2018
Cervical spinal cord atrophy: An early marker of progressive MS onsetBurcu Zeydan, Xinyi Gu, Elizabeth J Atkinson, et al.
Plos One|February 10, 2011
Switching multiple sclerosis patients with breakthrough disease to second-line therapyTamara Castillo-Trivino, Ellen M Mowry, Alberto Gajofatto, et al.
Annals of Neurology|November 25, 2015
Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated SyndromeOrhun H Kantarci, Christine Lebrun, Aksel Siva, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 3, 2015
(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areasEunkyung Park, Jean-Dominique Gallezot, Aracely Delgadillo, et al.
Genome Medicine|January 20, 2011
Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association dataJoanne H Wang, Derek Pappas, Philip L De Jager, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 7, 2017
The NAIMS cooperative pilot project: Design, implementation and future directionsJiwon Oh, Rohit Bakshi, Peter A Calabresi, et al.
Pageof 17